Jack Nathan Medical (TSE:JNH) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Jack Nathan Health reported a 16% year-to-date revenue growth in its Q3 fiscal 2025 results, driven primarily by its expanding operations in Mexico. The company has completed the sale of its Canadian operations and is focusing on growing its Mexican clinics and exploring opportunities in the MedSpa sector.
For further insights into TSE:JNH stock, check out TipRanks’ Stock Analysis page.